dispersjon

DRUG4 trials

Sponsors

Helse Bergen HF, Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Kuopio University Hospital

Conditions

Crohn's diseaseLymphatic ImagingPancreatic cancerbreast cancerhead & neck cancermelanoma

Phase 2

The role of sonoporation-enhanced treatment with Gemcitabine, Nab-Paclitaxel and FOLFIRINOX in patients with inoperable pancreatic cancer

Active, not recruitingCTIS2024-512176-35-00

Helse Bergen HFPancreatic cancer

Start: 2024-09-27Target: 60Updated: 2024-09-26

Contrast enhanced ultrasound a novel technique in lymphatic imaging - A prospective study

Not yet recruitingCTIS2024-519077-19-01

Kuopio University HospitalLymphatic Imaging

Target: 100Updated: 2024-12-04

Contrast-enhanced ultrasound for sentinel node detection in patients with melanoma, breast cancer or head & neck cancer (N24CUS)

RecruitingCTIS2024-515259-40-00

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichtingbreast cancer, head & neck cancer, melanoma

Start: 2025-07-07Target: 91Updated: 2024-12-09

Sonographic Diagnostics with Oral Contrast for Crohn’s disease 2. A novel method for detecting Crohns disease using sonographic intraluminal contrast

RecruitingCTIS2023-508500-38-00

Helse Bergen HFCrohn's disease

Start: 2025-09-12Target: 104Updated: 2025-04-11